Clinical Trials Browser

INDUSTRY × Recurrence × ixazomib × Clear all

NCT02343042 2025-12-22

STOMP

Phase 1/2 Recruiting

Multiple Myeloma, Recurrence

NCT03651128 2022-12-15

KarMMa-3

Phase 3 Active not recruiting

Multiple Myeloma, Recurrence

NCT00932698 2019-08-07

Study of Oral Ixazomib in Adult Participants With Relapsed and/or Refractory (RR) Multiple Myeloma

Phase 1 Completed

60 enrolled 34 charts

Multiple Myeloma, Recurrence